Serum TNF-α

Biomarker

1 paper studies it18 more mention it1 finding

  • Human trial1

Interventions

1

Allogeneic mesenchymal stem cells

downin humans1

1 study
  1. Allogeneic mesenchymal stem cells decrease serum TNF-α in humans (p = .03).

    “Serum TNF-α levels decreased in the 100M-group (p = .03).”

    Human trialaging frailty100-million-cell intravenous infusion100 million cells6 months postinfusion

    Allogeneic Mesenchymal Stem Cells Ameliorate Aging Frailty: A Phase II Randomized, Double-Blind, Placebo-Controlled Clinical Trial

    The journals of gerontology. Series A, Biological sciences and medical sciences

More on Allogeneic mesenchymal stem cells

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 1Jul 2026: 0Aug 2026: 1Sep 2026: 0Oct 2026: 13 papers in 12 months